Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-04-18FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care North America)
The FDA approved a supplemental application for DELFLEX, a dialysis solution, submitted by Fresenius Medical Care North America.
-
CLINICAL_TRIALS research · 2013-04-18Clinical Trial Update: EPLErenone in CsA-Treated Recipients (EpleCsAT): Safety [Phase 2]
Phase 2 trial update on the safety of eplerenone in cyclosporine-treated kidney transplant recipients with chronic kidney insufficiency; cur…
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Erythropoietin Resistance in Anemia of Chronic Kidney Disease
This clinical trial update reports on a completed study examining erythropoietin resistance in patients with anemia due to chronic kidney di…
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: Rosuvastatin Prevent Contrast Induced Acute Kidney Injury in Patients With Diabetes [Phase 4]
A Phase 4 trial evaluating rosuvastatin for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney …
-
CLINICAL_TRIALS research · 2013-04-10Clinical Trial Update: Quantification of Drugs and Their Degradation Products [NA]
This clinical trial update from University of Cologne describes a study focused on quantifying drugs and their degradation products. It note…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-04-04FDA Approved: OMNITROPE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Omnitrope (somatropin) from Sandoz Inc, potentially expanding or updating the product’s labe…
-
CLINICAL_TRIALS trial_result · 2013-03-29Clinical Trial Update: Oral Calcitriol for Reduction of Mild Proteinuria in Patients With CKD [Phase 4]
This is a status update on a Phase 4 clinical trial evaluating oral calcitriol to reduce mild proteinuria in patients with chronic kidney di…
-
CLINICAL_TRIALS withdrawal · 2013-03-29Clinical Trial Update: A Multi-Center, Open-Label Study [Phase 1]
This document reports a Phase 1, multi-center open-label study sponsored by Chelsea Therapeutics that has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-03-29Clinical Trial Update: The Role of Vitamin D in Immune Function in Patients With Chronic Kidney Disease (CKD) Stages 3 and 4. [Phase 4]
Phase 4 clinical trial investigating how vitamin D status affects immune function in patients with chronic kidney disease stage 3-4; status …
-
CLINICAL_TRIALS trial_result · 2013-03-29Clinical Trial Update: Comparison of Conventional Dialysis and the Allient System [NA]
This clinical trial compares conventional dialysis with the Allient System for patients with end-stage renal disease or chronic kidney disea…
-
CLINICAL_TRIALS trial_result · 2013-03-28Clinical Trial Update: N-Acetyl Cystein and Contrast Nephropathy [Phase 3]
Phase 3 clinical trial evaluating N-acetylcysteine for prevention of radiographic contrast–induced nephropathy in patients with chronic kidn…
-
CLINICAL_TRIALS research · 2013-03-27Clinical Trial Update: The Effect of Prophylactic Hemodialysis on the Morbidity and Mortality of the Patients With Chronic Kidney Disease Stages 3-4 Undergoing Coronary Artery Graft Bypass [Phase 2, Phase 3]
This entry describes a Phase 2/3 clinical trial evaluating whether prophylactic hemodialysis reduces morbidity and mortality in patients wit…
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: The Effect of Citrasate Dialysate on Heparin Dose in Hemodialysis [NA]
A completed clinical trial investigating how Citrasate Dialysate affects the heparin dose required during hemodialysis.
-
CLINICAL_TRIALS trial_result · 2013-03-22Clinical Trial Update: Isoflavones and Acute-phase Response in Chronic Renal Failure [Phase 2]
Phase 2 clinical trial update evaluating the effect of isoflavones on the acute-phase response in people with chronic kidney disease (kidney…
-
CLINICAL_TRIALS trial_result · 2013-03-13Clinical Trial Update: Evaluation of CLP in Heart Failure Patients With Chronic Kidney Disease [Phase 2]
Phase 2 trial evaluating CLP in heart failure patients with chronic kidney disease; results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: Paricalcitol Oral Therapy in Predialysis CKD Patients. The Greek Experience
This update reports results from a completed clinical trial evaluating oral paricalcitol for predialysis chronic kidney disease patients, in…
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: Does Thiazolidinedione Therapy Improve Endothelial Function and Preserve Renal Function [NA]
This terminated trial evaluated whether thiazolidinedione therapy improves endothelial function and preserves renal function in chronic kidn…
-
CLINICAL_TRIALS research · 2013-03-04Clinical Trial Update: NGAL Predictive Value of Acute Kidney Failure After Cardiac Surgery in Patients With Preoperative Chronic Kidney Failure
This clinical trial investigates whether the biomarker NGAL can predict acute kidney failure after cardiac surgery in patients with preexist…
-
CLINICAL_TRIALS trial_result · 2013-02-22Clinical Trial Update: Paricalcitol in Reducing Parathyroid Hormone Levels and Ameliorating Markers of Bone Remodelling in Renal Transplant Recipients With Secondary Hyperparathyroidism [Phase 2]
Phase 2 trial assessing paricalcitol's ability to lower parathyroid hormone levels and improve bone remodeling markers in renal transplant r…
-
CLINICAL_TRIALS trial_result · 2013-02-18Clinical Trial Update: Effect of Phosphate Binders on FGF-23 With Concurrent Calcitriol [Phase 4]
This update reports the completion of a Phase 4 trial evaluating the effect of phosphate binders on FGF-23 levels in chronic kidney disease,…
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: A Risk Based Approach to Improving Chronic Kidney Disease Management [Phase 3]
A Phase 3 clinical trial update describes a risk-based approach to improving management of chronic kidney disease. The study status is compl…
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Safety of Immunosuppression Minimization in Children and Adolescents After Kidney Transplantation [Phase 1]
This report updates findings from a Phase 1 trial evaluating safety of reducing immunosuppression in children and adolescents after kidney t…
-
CLINICAL_TRIALS research · 2013-02-15Clinical Trial Update: Effect Of Paricalcitol (Zemplar) On Endothelial Function And Inflammation In Type 2 Diabetes And Chronic Kidney Disease [NA]
A clinical trial update examining the effects of paricalcitol (Zemplar) on endothelial function and inflammation in people with type 2 diabe…
-
CLINICAL_TRIALS trial_result · 2013-02-13Clinical Trial Update: Safety Study of Renal Function in Patients With Chronic Kidney Failure Taking Lumiracoxib or Diclofenac for Arthralgia [Phase 2]
A Phase 2 safety study evaluating renal function in patients with chronic kidney disease taking lumiracoxib or diclofenac for arthralgia was…
-
CLINICAL_TRIALS trial_result · 2013-02-13Clinical Trial Update: Attenuation of the Side Effect Profile of Regadenoson: Study With Aminophylline in Patients With Severe Kidney Disease Undergoing Myocardial Perfusion Imaging [Phase 4]
Phase 4 trial evaluating whether aminophylline attenuates the side effect profile of regadenoson in patients with severe chronic kidney dise…